Patient Resource on Vascular Disorders: Understanding Hereditary Hemorrhagic Telangiectasia (HHT) - Takeaways - MDSpire

Patient Resource on Vascular Disorders: Understanding Hereditary Hemorrhagic Telangiectasia (HHT)

  • By

  • Rohan R Kasthuri

  • Harish Eswaran

  • Karen Smith

  • Raj S Kasthuri

  • February 3, 2026

  • 0 min

Share

  • 1

    Hereditary hemorrhagic telangiectasia (HHT) is a genetic disorder causing abnormal blood vessel growth, leading to telangiectasias and arteriovenous malformations (AVMs).

  • 2

    HHT is inherited in an autosomal dominant manner, affecting approximately 1 in 5000 people globally, with a 50% chance of transmission from an affected parent.

  • 3

    Common symptoms of HHT include recurrent nosebleeds, anemia, and the presence of telangiectasias, which can lead to serious complications from AVMs.

  • 4

    Diagnosis of HHT relies on clinical features known as the Curaçao criteria, requiring three specific symptoms or genetic testing for confirmation.

  • 5

    Early diagnosis and screening for AVMs are crucial in managing HHT to prevent severe complications, especially in children who may be asymptomatic.

Original Source(s)

Related Content